Certified by Founder Lodge
Complement Therapeutics
United Kingdom - London
START UP
1 Disclosed Funding Rounds $78,929,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 18 ,2023 | Series A | $78,929,000 | |
| April, 19 ,2023 | Series A | Undisclosed Amount |
Cambridge Innovation Capital
Gimv
Forbion
Seroba Life Sciences
Hadean Venture
Panakes Partners
BGV (BioGeneration Ventures)
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
BoldHue, Inc. | $3,400,000 | (Jul 3, 2024)
Tembo(US) | $14,000,000 | (Jul 3, 2024)
Cluby | $3,117,935 | (Jul 3, 2024)
Watchyourhealth.com | $5,000,000 | (Jul 3, 2024)
Redactive | $7,500,000 | (Jul 3, 2024)
